AngioDynamics ANGO Accounts Receivable Net Current
Accounts Receivable Net Current at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: AngioDynamics’s 10-K, filed July 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's accounts receivable net current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's accounts receivable net current?
- AngioDynamics (ANGO) reported accounts receivable net current of $48.33M in Q1 2026.
- How has AngioDynamics's accounts receivable net current changed year-over-year?
- AngioDynamics's accounts receivable net current increased by 12.7% year-over-year, from $42.89M to $48.33M.
- What is the long-term trend for AngioDynamics's accounts receivable net current?
- Over 5 years (2021 to 2026), AngioDynamics's accounts receivable net current has grown at a 6.4% compound annual growth rate (CAGR), from $35.41M to $48.33M.
- What does accounts receivable net current mean?
- This metric represents the total amount of money owed to the company by customers for medical devices and services delivered, net of any allowances for doubtful accounts. It serves as a key indicator of the company's credit management efficiency and the speed at which it converts sales into cash. Monitoring this balance helps investors assess the liquidity risk associated with the company's customer base and the effectiveness of its collection processes.